Innovations in core-shell nanoparticles advancing drug delivery and precision medicine

A new expert review in the peer-reviewed OMICS: A Journal of Integrative Biology, explores how core-shell nanoparticles could revolutionize drug delivery systems and play a key role in advancing personalized and precision medicine. Click here to read the article now.

Suren A. Ramadhan, from Knowledge University in Erbil, Iraq, and Diyar S. Ali, from Knowledge University and Salahaddin University-Erbil, describe the benefits of core-shell nanoparticles, which provide effective drug encapsulation, shielding the drug from degradation and allowing for controlled release.

“By enabling targeted drug release, this controlled mechanism can help improve treatment outcomes and reduce side effects,” stated the authors.

Various materials, including polymers, lipids, and inorganic substances, can be used to create these nanoparticles, and these materials can be tailored for better drug loading, compatibility with the host organism, and specific chemical properties to suit different therapeutic needs.

“This innovation analysis highlights the emerging convergence of nanotechnology with precision/personalized medicine by unpacking the advances in drug delivery being enabled by core-shell nanoparticles,” says Vural Özdemir, MD, MSc, PhD, DABCP, MA, Editor-in-Chief of OMICS.

About the Journal
OMICS: A Journal of Integrative Biology is an authoritative and highly innovative peer-reviewed interdisciplinary journal published monthly online, addressing the latest advances at the intersection of postgenomics medicine, biotechnology and global society, including the integration of multi-omics knowledge, data analyses and modeling, and applications of high-throughput approaches to study complex biological and societal problems. Public policy, governance and societal aspects of large-scale biology and 21st century data-enabled sciences are also peer-reviewed. Complete tables of content and a sample issue may be viewed on the OMICS: A Journal of Integrative Biology website.

About the Publisher
Mary Ann Liebert, Inc., a Sage company is a global media company dedicated to publishing and delivering impactful peer-reviewed research in biotechnology and life sciences, specialized clinical medicine, and public health and policy, and technology & engineering. Since its founding in 1980, the company has focused on providing critical insights and content that empower researchers and clinicians worldwide to drive innovation and discovery.